Synapticure Analysis: $6M Raised
What is Synapticure?
Synapticure provides virtual specialty care for people living with neurodegenerative diseases, including dementia, ALS, Parkinson’s, and related movement disorders. The company operates across all 50 states and says most visits are covered by insurance, with care delivered by neurologists, behavioral health providers, and care coordinators. Synapticure also runs the CMS GUIDE model for dementia support and offers caregiver services, respite care, and 24/7 support.
Location
2045 W Grand Ave Ste B, Chicago, Illinois 60612, United States
Employees
51-200
Founded
2019
Revenue
$5-21M
Product Features & Capabilities
- Cognitive Care, Alzheimer's Disease support, Frontotemporal Dementia services, Lewy Body Dementia services, Movement Care for Parkinson's Disease, Huntington's Disease support, Neuromuscular Care for ALS and Primary Lateral Sclerosis, Mental Health Care, Care Coordination, Insurance Management & Prior Authorization, Proactive Genetic Testing & Counseling, Clinical Trials & Investigational Therapies.
Pricing
- First consultation with a Care Coordinator is free.
- No subscription fee; services billed to health plans.
- Average cost for in-network visits is $0-40.
How much Synapticure raised
Seed - $6 million
February 1, 2022Lead Investor: Led by GV (formerly Google Ventures)
Who are the founders of Synapticure
PW
Peter Wallach
Founder / Founding CEO
BW
Brian Wallach
Founder
MD
Martina de Majo
Director of Research and Development
HQ Full Address
2045 W Grand Ave Ste B, Chicago, Illinois 60612, United States
Market Focus
Synapticure primarily focuses on the telehealth industry, specifically providing services for patients with neurodegenerative diseases such as ALS, Parkinson's, Alzheimer's, and other dementias.
Investors
- B Capital
- CommonSpirit Health
- CVS Health Ventures
- RA Capital Management
- Nexus NeuroTech Ventures
Business Model
Revenue from insurance billing for telehealth services and partnerships with healthcare providers.
Competitors Overview
Synapticure operates in the telehealth market for neurodegenerative diseases, facing competition from several notable companies:
-
Rippl Care: Focuses on providing mental health services for seniors, particularly those with neurodegenerative conditions. Their advantage lies in a specialized approach to mental health, which is crucial for patients dealing with diseases like Alzheimer's and Parkinson's.
-
Isaac Health: Offers virtual and in-home clinical services specifically for dementia and other brain health conditions. Their evidence-based care model emphasizes screening, diagnosis, treatment, and ongoing management, which can provide a more comprehensive care pathway compared to Synapticure's focus on telehealth.
-
Alignment Health: While primarily focused on health insurance, they provide integrated care solutions that may include telehealth services for chronic conditions, including neurodegenerative diseases. Their advantage is in their broader healthcare integration, which can offer patients a more holistic approach.
-
Jasper Health: Specializes in personalized care management for chronic conditions, including neurodegenerative diseases. Their focus on personalized care plans and coordination with healthcare providers can enhance patient outcomes.
-
Mindoula Health: Provides a combination of telehealth and in-person services, focusing on mental health and chronic disease management. Their integrated model allows for a more comprehensive approach to patient care, addressing both physical and mental health needs.
Each of these competitors has unique strengths, such as specialized mental health services, comprehensive care models, and integrated healthcare solutions, which may differentiate them from Synapticure's telehealth-centric approach.
See something that needs updating? Suggest edits to this profile.